Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?

Annelieke Pasma*, Charlotte Schenk, Reinier Timman, Adriaan van 't Spijker, Cathelijne Appels, Willemijn H. van der Laan, Bart van den Bemt, Robert Goekoop, Johanna M. W. Hazes, Jan J. V. Busschbach

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number0171070
Number of pages14
JournalPLOS ONE
Volume12
Issue number2
DOIs
Publication statusPublished - 2 Feb 2017

Keywords

  • EARLY RHEUMATOID-ARTHRITIS
  • MEDICATION ADHERENCE
  • DRUG-THERAPY
  • RECOMMENDATIONS
  • ASSOCIATION
  • DEPRESSION
  • MORTALITY
  • ANXIETY
  • WORK
  • RISK

Cite this